CODX
Co-Diagnostics Inc. (CODX)
NASDAQ · Healthcare
Co-Diagnostics Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Co-Diagnostics Inc. revenue for the quarter ending March 31, 2026 was 145954, a 190.30% increase year-over-year.
- Co-Diagnostics Inc. revenue for the twelve months ending March 31, 2026 was 504521, a 91.89% decrease year-over-year.
- Co-Diagnostics Inc. annual revenue for 2025 was 622489, a 84.10% decrease from 2024.
- Co-Diagnostics Inc. annual revenue for 2024 was 3.9 M, a 42.53% decrease from 2023.
- Co-Diagnostics Inc. annual revenue for 2023 was 6.8 M, a 80.09% decrease from 2022.
- Co-Diagnostics Inc. annual revenue for 2022 was 34.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Co-Diagnostics Inc. Earnings — FAQ
Co-Diagnostics Inc. (CODX) earnings over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CODX's earnings history?
The chart and table above show Co-Diagnostics Inc.'s earnings by year and by quarter, including the growth rate.